Whanin Pharm Co Ltd
KRX:016580
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Whanin Pharm Co Ltd
Unrealized Security Profit/Loss
Whanin Pharm Co Ltd
Unrealized Security Profit/Loss Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Unrealized Security Profit/Loss | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
Whanin Pharm Co Ltd
KRX:016580
|
Unrealized Security Profit/Loss
₩972.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Unrealized Security Profit/Loss
₩74.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-16%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Unrealized Security Profit/Loss
₩25.4B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Unrealized Security Profit/Loss
-₩44.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Unrealized Security Profit/Loss
₩650.3m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
24%
|
CAGR 10-Years
24%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Unrealized Security Profit/Loss
-₩50.2m
|
CAGR 3-Years
54%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Whanin Pharm Co Ltd
Glance View
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. The company is headquartered in Seoul, Seoul. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The firm also involves in the real estate rental business.
See Also
What is Whanin Pharm Co Ltd's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
972.9m
KRW
Based on the financial report for Dec 31, 2025, Whanin Pharm Co Ltd's Unrealized Security Profit/Loss amounts to 972.9m KRW.
